As foreign powers approve Ebola vaccines, U.S. drug makers lag in development pipeline


In the face of the West Africa Ebola crisis, U.S and Canadian government laboratories and a number of companies in Europe raced to test experimental vaccines.

A year and a half after that outbreak was declared over, the world has two licensed Ebola vaccines: One was made by scientists in Russia, the other by scientists in China. Continue reading. Continue reading.